Below is a detailed analysis of the quarterly data for KSB Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 595.00 Cr.. The value appears to be declining and may need further review. It has decreased from 726.00 Cr. (Dec 2024) to 595.00 Cr., marking a decrease of 131.00 Cr..
For Expenses, as of Mar 2025, the value is 528.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 628.00 Cr. (Dec 2024) to 528.00 Cr., marking a decrease of 100.00 Cr..
For Operating Profit, as of Mar 2025, the value is 68.00 Cr.. The value appears to be declining and may need further review. It has decreased from 98.00 Cr. (Dec 2024) to 68.00 Cr., marking a decrease of 30.00 Cr..
For OPM %, as of Mar 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 14.00% (Dec 2024) to 11.00%, marking a decrease of 3.00%.
For Other Income, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Dec 2024) to 16.00 Cr., marking an increase of 2.00 Cr..
For Interest, as of Mar 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Dec 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 14.00 Cr..
For Profit before tax, as of Mar 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 98.00 Cr. (Dec 2024) to 69.00 Cr., marking a decrease of 29.00 Cr..
For Tax %, as of Mar 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 25.00%.
For Net Profit, as of Mar 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Dec 2024) to 52.00 Cr., marking a decrease of 21.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 2.96. The value appears to be declining and may need further review. It has decreased from 4.20 (Dec 2024) to 2.96, marking a decrease of 1.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: May 3, 2025, 3:25 pm
Metric
Dec 2013
Dec 2014
Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
TTM
Sales
731
802
819
826
946
1,093
1,294
1,208
1,497
1,822
2,247
2,533
2,584
Expenses
629
701
713
720
838
965
1,142
1,039
1,287
1,575
1,954
2,196
2,240
Operating Profit
102
101
106
106
108
128
152
169
210
247
294
338
344
OPM %
14%
13%
13%
13%
11%
12%
12%
14%
14%
14%
13%
13%
13%
Other Income
12
23
24
29
35
24
40
33
40
50
42
50
54
Interest
3
2
2
3
4
4
5
3
5
6
5
3
3
Depreciation
27
28
28
29
31
40
46
42
44
45
50
54
55
Profit before tax
86
94
100
103
108
109
140
157
201
245
280
331
340
Tax %
33%
34%
36%
33%
34%
34%
28%
40%
26%
25%
26%
25%
Net Profit
67
68
69
69
71
72
101
94
149
183
209
247
254
EPS in Rs
3.84
3.93
3.95
3.94
4.07
4.12
5.79
5.39
8.59
10.50
12.00
14.22
14.62
Dividend Payout %
29%
28%
28%
28%
29%
29%
28%
32%
29%
29%
29%
28%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)
No data available for trend analysis.
Growth
Compounded Sales Growth
10 Years:
12%
5 Years:
14%
3 Years:
19%
TTM:
12%
Compounded Profit Growth
10 Years:
14%
5 Years:
22%
3 Years:
18%
TTM:
20%
Stock Price CAGR
10 Years:
22%
5 Years:
53%
3 Years:
45%
1 Year:
-12%
Return on Equity
10 Years:
14%
5 Years:
16%
3 Years:
17%
Last Year:
18%
Last Updated: Unknown
No data available for the Balance Sheet data table.
After reviewing the key financial ratios for KSB Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Dec 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Dec 22) which recorded 10.00.
For Basic EPS (Rs.), as of Dec 23, the value is 59.97. This value is within the healthy range. It has increased from 52.50 (Dec 22) to 59.97, marking an increase of 7.47.
For Diluted EPS (Rs.), as of Dec 23, the value is 59.97. This value is within the healthy range. It has increased from 52.50 (Dec 22) to 59.97, marking an increase of 7.47.
For Cash EPS (Rs.), as of Dec 23, the value is 71.53. This value is within the healthy range. It has increased from 63.26 (Dec 22) to 71.53, marking an increase of 8.27.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 374.02. It has increased from 328.41 (Dec 22) to 374.02, marking an increase of 45.61.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 374.02. It has increased from 328.41 (Dec 22) to 374.02, marking an increase of 45.61.
For Revenue From Operations / Share (Rs.), as of Dec 23, the value is 645.61. It has increased from 523.43 (Dec 22) to 645.61, marking an increase of 122.18.
For PBDIT / Share (Rs.), as of Dec 23, the value is 93.63. This value is within the healthy range. It has increased from 82.98 (Dec 22) to 93.63, marking an increase of 10.65.
For PBIT / Share (Rs.), as of Dec 23, the value is 79.36. This value is within the healthy range. It has increased from 69.97 (Dec 22) to 79.36, marking an increase of 9.39.
For PBT / Share (Rs.), as of Dec 23, the value is 77.84. This value is within the healthy range. It has increased from 68.22 (Dec 22) to 77.84, marking an increase of 9.62.
For Net Profit / Share (Rs.), as of Dec 23, the value is 57.26. This value is within the healthy range. It has increased from 50.25 (Dec 22) to 57.26, marking an increase of 7.01.
For NP After MI And SOA / Share (Rs.), as of Dec 23, the value is 59.97. This value is within the healthy range. It has increased from 52.50 (Dec 22) to 59.97, marking an increase of 7.47.
For PBDIT Margin (%), as of Dec 23, the value is 14.50. This value is within the healthy range. It has decreased from 15.85 (Dec 22) to 14.50, marking a decrease of 1.35.
For PBIT Margin (%), as of Dec 23, the value is 12.29. This value is within the healthy range. It has decreased from 13.36 (Dec 22) to 12.29, marking a decrease of 1.07.
For PBT Margin (%), as of Dec 23, the value is 12.05. This value is within the healthy range. It has decreased from 13.03 (Dec 22) to 12.05, marking a decrease of 0.98.
For Net Profit Margin (%), as of Dec 23, the value is 8.86. This value is within the healthy range. It has decreased from 9.60 (Dec 22) to 8.86, marking a decrease of 0.74.
For NP After MI And SOA Margin (%), as of Dec 23, the value is 9.28. This value is within the healthy range. It has decreased from 10.02 (Dec 22) to 9.28, marking a decrease of 0.74.
For Return on Networth / Equity (%), as of Dec 23, the value is 16.03. This value is within the healthy range. It has increased from 15.98 (Dec 22) to 16.03, marking an increase of 0.05.
For Return on Capital Employeed (%), as of Dec 23, the value is 20.47. This value is within the healthy range. There is no change compared to the previous period (Dec 22) which recorded 20.47.
For Return On Assets (%), as of Dec 23, the value is 10.10. This value is within the healthy range. It has increased from 10.01 (Dec 22) to 10.10, marking an increase of 0.09.
For Total Debt / Equity (X), as of Dec 23, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Dec 22) which recorded 0.00.
For Asset Turnover Ratio (%), as of Dec 23, the value is 1.16. It has increased from 1.06 (Dec 22) to 1.16, marking an increase of 0.10.
For Current Ratio (X), as of Dec 23, the value is 2.05. This value is within the healthy range. It has increased from 2.01 (Dec 22) to 2.05, marking an increase of 0.04.
For Quick Ratio (X), as of Dec 23, the value is 1.15. This value is within the healthy range. It has increased from 1.12 (Dec 22) to 1.15, marking an increase of 0.03.
For Inventory Turnover Ratio (X), as of Dec 23, the value is 1.78. This value is below the healthy minimum of 4. It has decreased from 1.82 (Dec 22) to 1.78, marking a decrease of 0.04.
For Dividend Payout Ratio (NP) (%), as of Dec 23, the value is 25.01. This value is within the healthy range. It has increased from 23.80 (Dec 22) to 25.01, marking an increase of 1.21.
For Dividend Payout Ratio (CP) (%), as of Dec 23, the value is 20.20. This value is within the healthy range. It has increased from 19.08 (Dec 22) to 20.20, marking an increase of 1.12.
For Earning Retention Ratio (%), as of Dec 23, the value is 74.99. This value exceeds the healthy maximum of 70. It has decreased from 76.20 (Dec 22) to 74.99, marking a decrease of 1.21.
For Cash Earning Retention Ratio (%), as of Dec 23, the value is 79.80. This value exceeds the healthy maximum of 70. It has decreased from 80.92 (Dec 22) to 79.80, marking a decrease of 1.12.
For Interest Coverage Ratio (X), as of Dec 23, the value is 61.61. This value is within the healthy range. It has increased from 47.15 (Dec 22) to 61.61, marking an increase of 14.46.
For Interest Coverage Ratio (Post Tax) (X), as of Dec 23, the value is 38.68. This value is within the healthy range. It has increased from 29.55 (Dec 22) to 38.68, marking an increase of 9.13.
For Enterprise Value (Cr.), as of Dec 23, the value is 11,783.45. It has increased from 6,480.95 (Dec 22) to 11,783.45, marking an increase of 5,302.50.
For EV / Net Operating Revenue (X), as of Dec 23, the value is 5.24. This value exceeds the healthy maximum of 3. It has increased from 3.56 (Dec 22) to 5.24, marking an increase of 1.68.
For EV / EBITDA (X), as of Dec 23, the value is 36.16. This value exceeds the healthy maximum of 15. It has increased from 22.44 (Dec 22) to 36.16, marking an increase of 13.72.
For MarketCap / Net Operating Revenue (X), as of Dec 23, the value is 5.37. This value exceeds the healthy maximum of 3. It has increased from 3.70 (Dec 22) to 5.37, marking an increase of 1.67.
For Retention Ratios (%), as of Dec 23, the value is 74.98. This value exceeds the healthy maximum of 70. It has decreased from 76.19 (Dec 22) to 74.98, marking a decrease of 1.21.
For Price / BV (X), as of Dec 23, the value is 9.26. This value exceeds the healthy maximum of 3. It has increased from 5.90 (Dec 22) to 9.26, marking an increase of 3.36.
For Price / Net Operating Revenue (X), as of Dec 23, the value is 5.37. This value exceeds the healthy maximum of 3. It has increased from 3.70 (Dec 22) to 5.37, marking an increase of 1.67.
For EarningsYield, as of Dec 23, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Dec 22) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of KSB Ltd as of June 13, 2025 is: 686.51
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of June 13, 2025, KSB Ltd is Overvalued by 17.09% compared to the current share price 828.00
Intrinsic Value of KSB Ltd as of June 13, 2025 is: 763.55
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of June 13, 2025, KSB Ltd is Overvalued by 7.78% compared to the current share price 828.00
Last 5 Year EPS CAGR: 11.22%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in KSB Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 16.03% (Industry Average ROE: 16.7%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 56.5 (Industry average Stock P/E: 43.3)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
KSB Ltd. is a Public Limited Listed company incorporated on 11/04/1960 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L29120MH1960PLC011635 and registration number is 011635. Currently Company is involved in the business activities of Manufacture of other pumps, compressors, taps and valves. Company's Total Operating Revenue is Rs. 2533.10 Cr. and Equity Capital is Rs. 34.80 Cr. for the Year ended 31/12/2024.
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in KSB Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
